Dr. William Dalton is CEO of M2Gen, a Moffitt Cancer Center biotechnology company. Additionally, he is founding director of Moffitt’s Personalized Medicine Institute, established in 2012 to focus on Moffitt’s brand of personalized medicine, Total Cancer Care®. Dr. Dalton served as president and CEO of Moffitt from 2002 to 2012 and was instrumental in helping the Cancer Center achieve tremendous growth and innovation.
Dalton's research concerns drug discovery, the biochemical mechanisms of drug resistance, and the biology and treatment of multiple myeloma. He has published over 250 articles in peer-reviewed scientific and medical journals, which have been cited over 12,000 times, resulting in an h-index of 58.
years treating myeloma:
Number of Myeloma Patients Treated Annually:
Details & contact info
H. Lee Moffitt Cancer Center (MCC) USF Citrus Drive
Tampa, FL, United States, 33620
Send a message to William Dalton, PHD, MD